Drug Database
Back to search

Switzerland· 55585012

Pegasys 135 mcg/0,5 ml, Injektionslösung in einer Fertigspritze

A peginterferon alfa-2a product containing peginterferonum alfa-2a, registered in Switzerland by CPS Cito Pharma Services GmbH and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L03AB11

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPegasys 135 mcg/0,5 ml, Injektionslös…ATCL03AB11REGISTER NO.55585012PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about peginterferonum alfa-2aAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Peginterferon alfa-2a is registered in 14 of 19 countries.

Countries holding a registration under ATC L03AB11 (peginterferon alfa-2a), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search peginterferon alfa-2a products by name

Peginterferon alfa-2a · ATC L03AB11

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
peginterferonum alfa-2a
Manufacturer
CPS Cito Pharma Services GmbH
Country
Switzerland (CH)
ATC code
L03AB11
ATC class
Peginterferon alfa-2a
Defined daily dose
26 mcg, P
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680555850126
    4 Fertspr 0.5 ml
    CHF 625.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

201 interactions on record for peginterferon alfa-2a.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check peginterferon alfa-2a against other medicinesHow interaction checks work

Peginterferon alfa-2a · interactions on record

201 records

  • 35 severe
  • 163 moderate
  • 3 minor

Most severe, free to view

  • EltrombopagB02BX05severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • TelbivudineJ05AF11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Peginterferon alfa-2a in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All peginterferon alfa-2a products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Pegasys
  • Liechtenstein · Pegasys
  • Norway · Pegasys

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a0d6fcd7-9f47-47a6-a9b2-b8b949a29754
GET /v1/drugs/a0d6fcd7-9f47-47a6-a9b2-b8b949a29754?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "peginterferonum alfa-2a 135 mcg",
  "valid_from": "2003-03-01",
  "limitations": "[{\"description\":\"Vergütung der Behandlung der chronischen Hepatitis B (CHB) bei Erwachsenen.<br>\\n<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2019-12-01\"}]",
  "galenic_form": "Inj Lös 135 mcg/0.5 ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2003-03-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about peginterferon alfa-2a.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console